CAS 1612838-76-2

Risankizumab

CAS: 1612838-76-2

Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.

Purezza: SDS-PAGE:95.3%;SEC-HPLC:98.3%

Colore e forma: Liquid

Peso molecolare: 145.85 kDa

Ref: TM-T76778

Risankizumab

CAS: 1612838-76-2

Anti-Human IL-23α Monoclonal Antibody

Ref: 3D-CLA1403